Plenge Robert M (CIK 1773367) reported 10 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-14). Recent activity: Buy BMRN (6,140 shares), Buy BMY (1,107 shares), Sell BMY (124 shares), Sell BMY (436 shares), Buy BMY (2,342 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-14 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Director | Buy | 6,140 | $0 |
| 2026-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, Chief Research Officer | Buy | 1,107 | $0 |
| 2026-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, Chief Research Officer | Sell | 124 | $0 |
| 2026-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, Chief Research Officer | Sell | 436 | $26,217 |
| 2026-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, Chief Research Officer | Buy | 2,342 | $0 |
| 2026-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, Chief Research Officer | Sell | 253 | $0 |
| 2026-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, Chief Research Officer | Sell | 927 | $55,741 |
| 2026-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, Chief Research Officer | Buy | 14,052 | $0 |
| 2026-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, Chief Research Officer | Sell | 6,900 | $0 |
| 2026-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, Chief Research Officer | Sell | 3,172 | $190,732 |
来源：SEC Form 4 申报文件 · 截至 2026-09-14